Wednesday, July 1, 2026 See who Washington just made rich Go Pro · $20/mo →
Money Racket
Who Cashes In When Washington Moves
DEFENSELockheed Martin Lands $35B THAAD Contract to Quadruple Missile ProductiontodayENERGYDOE's $17.5B in Federal Loans Is Reshaping the Nuclear Energy Investment CasetodayTECHTrump's Quantum Orders Set Hard Deadlines for Post-Quantum Cryptography — and Create a Compliance MarkettodayTECHTrump Administration Lifts Export Controls on Anthropic's Claude AI ModelstodayWHITE HOUSEU.S.-Iran Ceasefire Deal Signed, but White House Asks Congress for $87.6B to Cover the War's TabtodayHEALTHCARE & FDADOJ's $6.5B Healthcare Fraud Takedown Puts Medicare Advantage Billing Under a MicroscopetodayCRYPTOBitcoin ETF Outflows Top $4 Billion in June as Citi Cuts Its Price ForecasttodayTRADE & TARIFFSTrump Suspends Fertilizer Tariffs, Cutting Input Costs for U.S. FarmerstodayMARKETSSupreme Court Gives Trump Power to Fire FTC Commissioners, Sparing the FedtodayHEALTHCARE & FDAFDA Launches Safety Reassessment of BHT and ADA, Two Additives in Millions of Food Productstoday
Peptides & Growth Factors

Exosomes

Cell-derived vesicles delivering growth factors and signaling molecules.

Also known as: Extracellular vesicles, exosome-derived products, cell-derived vesicles, engineered exosomes.

What it is
Exosomes are tiny membrane-bound vesicles (30–150 nm) naturally released by cells, containing proteins, lipids, and nucleic acids. In skincare, they're typically derived from stem cells, fibroblasts, or plant cells and are used to deliver bioactive compounds that may stimulate collagen, reduce inflammation, and support skin repair.
What it does
Exosomes act as intercellular messengers, transferring growth factors and signaling molecules into skin cells. They may trigger fibroblast activity, promote collagen synthesis, reduce inflammatory cytokines, and enhance skin barrier function. The mechanism relies on their cargo—primarily growth factors like EGF, FGF, and TGF-β—and their ability to fuse with or be internalized by target cells.
The evidence
Evidence is emerging and mixed. In vitro and animal studies show exosomes can stimulate collagen and reduce inflammation; human clinical data in skincare is limited and often proprietary. Most published human studies are small, short-term, or sponsored by manufacturers. The field lacks independent, large-scale RCTs confirming efficacy in topical or injectable formats.
Best for
Aging skin, loss of elasticity, dull or damaged skin, and post-procedure recovery; best suited for patients seeking advanced, science-forward treatments.
Pairs well with
Retinoids, vitamin C, hyaluronic acid, peptides, and other growth factors; often used in combination protocols for enhanced skin rejuvenation.
Use cautiously with
No major conflicts, but combining multiple growth-factor products may risk over-stimulation or irritation in sensitive skin; use cautiously with active exfoliants immediately post-treatment.
Cautions
Exosome products vary widely in source, purity, and potency; regulatory oversight is limited. Allergic reactions or irritation are possible, especially with non-human-derived sources. Pregnant patients should consult a physician. Injectable exosomes carry standard injection risks; topical absorption is uncertain and likely minimal without penetration enhancers.
General information, not medical advice. Ingredient effects vary by formulation, concentration, and skin. Patch-test new actives and consult a qualified provider before starting prescription ingredients.

Know what's coming before your patients ask for it.

New actives, device launches, and the FDA calls that change what you can offer — distilled into a two-minute brief, twice a week. Inside MedSpa Pro.

Go Pro · $20/mo
Money Racket Pro

By the time it's news, the money's already moved.

The contract award, the executive order, the tariff cut — it mints winners before the financial press connects the dots. Pro gets you there first: what happened, who cashes in, and exactly what to watch — in a two-minute read.

Go Pro · $20/mo The policy-to-profit brief. Cancel anytime.
The twice-a-week profit brief Go Pro · $20/mo